| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/26/2013 | US20130251710 Methods to Expand the Eligible Patient Population for HER2-Directed Targeted Therapies |
| 09/26/2013 | US20130251709 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of acute myelogenous leukemia |
| 09/26/2013 | US20130251706 Combined use of fc gamma riib (cd32b) and cd20 - specific antibodies |
| 09/26/2013 | US20130251705 Compositions and methods for diagnosing and treating cancer |
| 09/26/2013 | US20130251703 Antibodies for epidermal growth factor receptor 3 (her3) directed to domain iii and domain iv of her3 |
| 09/26/2013 | US20130251675 Methods for Modulating Inflammatory Responses |
| 09/26/2013 | US20130251672 Method and system to remove soluble tnfr1, tnfr2 and il2 in patients |
| 09/26/2013 | US20130251671 Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes |
| 09/25/2013 | EP2641919A2 Antigen-binding constructs |
| 09/25/2013 | EP2641918A2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 09/25/2013 | EP2641917A2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 09/25/2013 | EP2641914A1 Monoclonal antibody capable of recognizing human papilloma virus (hpv) l2 protein, and method for measuring hpv-neutralizing antibody titer using same |
| 09/25/2013 | EP2641913A2 Immunoglobulin constant region Fc receptor binding agents |
| 09/25/2013 | EP2641912A1 Process for obtaining an IgG composition through heat treatment |
| 09/25/2013 | EP2641618A2 Humanized anti-CD79B antibodies and immunoconjugates and methods of use |
| 09/25/2013 | EP2641613A1 Liquid norovirus vaccine formulations comprising toll-like receptor (TLR) agonist as adjuvant |
| 09/25/2013 | EP2641612A1 Alpha 5 - beta 1 antibodies and their uses |
| 09/25/2013 | EP2641611A2 Combination therapy |
| 09/25/2013 | EP2641601A1 Methods of treating multiple myeloma using combination therapies based on HuLuc63 with bortezimob |
| 09/25/2013 | EP2641600A1 Methods of Treating Multiple Myeloma Using Combination Therapies based on Anti-CS1 Antibodies |
| 09/25/2013 | EP2640842A1 Methods and compositions for inducing an immune response to egfrviii |
| 09/25/2013 | EP2640832A1 New ethiological agent |
| 09/25/2013 | EP2640831A1 Influenza virus neutralizing agents that mimic the binding site of an influenza neutralizing antibody |
| 09/25/2013 | EP2640751A1 Lipidated polyepitope vaccines |
| 09/25/2013 | EP2640748A1 Luteinizing-hormone ligand and ligand-gonadotrophin complex |
| 09/25/2013 | EP2640744A2 Neutralizing anti-ccl20 antibodies |
| 09/25/2013 | EP2640727A1 Alaninyl maytansinol antibody conjugates |
| 09/25/2013 | EP2640421A1 Regimens for treatments using anti-igf antibodies |
| 09/25/2013 | EP2640419A1 Respiratory syncytial virus vaccine |
| 09/25/2013 | EP2640418A1 Immunogenic compositions |
| 09/25/2013 | EP2640417A2 Multivalent vaccine for filariasis |
| 09/25/2013 | EP2640416A1 Combination therapy for b cell lymphomas |
| 09/25/2013 | EP2640415A1 Cross protective epitopes of aspergillus fumigatus and candida albicans |
| 09/25/2013 | EP2640414A1 Immunoglobulin cleavage fragments vaccine compositions |
| 09/25/2013 | EP2640385A1 Preselection of subjects for therapeutic treatment based on hypoxic status |
| 09/25/2013 | EP2640377A1 Fgfr1 extracellular domain combination therapies |
| 09/25/2013 | EP2640359A2 Novel compositions and uses of anti-hypertension agents for cancer therapy |
| 09/25/2013 | EP2640186A1 Leishmania canine challenge model by sand fly bites |
| 09/25/2013 | EP2520589A9 Anti-cd27 antibody |
| 09/25/2013 | EP2275119B1 Stable isotonic lyophilized protein formulation |
| 09/25/2013 | DE202013007396U1 Kit zur Herstellung eines Impfstoffs Kit for the preparation of a vaccine |
| 09/25/2013 | CN103328647A Recombinant flaviviral constructs and uses thereof |
| 09/25/2013 | CN103328632A Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
| 09/25/2013 | CN103328629A Novel vaccines against the a/H1N1 pandemic flu virus |
| 09/25/2013 | CN103328513A Anti CCR4 antibodies and uses thereof |
| 09/25/2013 | CN103328511A Anti-Il-1 beta antibodies and methods of use |
| 09/25/2013 | CN103328510A Luteinizing-hormone ligand and ligand-gonadotrophin complex |
| 09/25/2013 | CN103328506A Therapies for improving pulmonary function |
| 09/25/2013 | CN103328505A Non-antagonistic EGFR-binding molecules and immunoconjugates thereof |
| 09/25/2013 | CN103328005A Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells |
| 09/25/2013 | CN103328004A Infectious hepatitis E virus genotype 3 recombinants |
| 09/25/2013 | CN103328003A An epstein-barr-virus vaccine |
| 09/25/2013 | CN103328002A Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 09/25/2013 | CN103328001A Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy |
| 09/25/2013 | CN103327997A Moesin modulators and uses thereof |
| 09/25/2013 | CN103327988A Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof |
| 09/25/2013 | CN103327976A Preselection of subjects for therapeutic treatment based on hypoxic status |
| 09/25/2013 | CN103327963A Cationic oil-in-water emulsions |
| 09/25/2013 | CN103320451A Genetic engineering protein vaccine for preventing EV71, and preparation method thereof |
| 09/25/2013 | CN103320394A Method for preparing virus-like particle and recombinant baculovirus used therein |
| 09/25/2013 | CN103319604A Human rotavirus Delta VP8* subunit recombinant protein and application thereof |
| 09/25/2013 | CN103319602A 疫苗载体 Vaccine vector |
| 09/25/2013 | CN103319601A 疫苗载体 Vaccine vector |
| 09/25/2013 | CN103319600A Humanized anti-TLR4 antibody Fab as well as preparation method and application thereof |
| 09/25/2013 | CN103319598A Insulin-like growth factor-1 receptor (IGF-1R) resistant antibody and coding genes and applications thereof |
| 09/25/2013 | CN103319597A Insulin-like growth factor-1 receptor (IGF-1R) resistant antibody and coding genes and applications thereof |
| 09/25/2013 | CN103319596A Compositions and methods for increasing bone mineralization |
| 09/25/2013 | CN103319595A Preparation method and application of anti-human alpha fetoprotein (AFP) single-chain antibody and fusion antigen peptide |
| 09/25/2013 | CN103319593A Anti StxII monoclonal antibody |
| 09/25/2013 | CN103319577A Haemophilus parasuis (Hps) immunoprotecive antigen OppA |
| 09/25/2013 | CN103319576A Haemophilus parasuis (Hps) immunoprotecive antigen AfuA |
| 09/25/2013 | CN103319575A Haemophilus parasuis (Hps) immunoprotecive antigen CdtB |
| 09/25/2013 | CN103319573A Method for producing classical swine fever virus subunit vaccine by utilizing bombyx mori bioreactor |
| 09/25/2013 | CN103316371A Improved method for producing oocysts |
| 09/25/2013 | CN103316358A Bivalent DNA (Deoxyribonucleic Acid) vaccine and preparation method thereof |
| 09/25/2013 | CN103316357A Recombinant influenza virus chimeric vaccine carrying RSV gene, and preparation method thereof |
| 09/25/2013 | CN103316355A Pseudorabies live vaccine and preparation method thereof |
| 09/25/2013 | CN103316339A Hepatitis b vaccine for low and non response people and preparation method thereof |
| 09/25/2013 | CN103316338A Health-care immunization needle injection method of piglet |
| 09/25/2013 | CN103316337A Construction of vaccinia virus vector gene modification system, and application of recombinant coronavirus |
| 09/25/2013 | CN103316336A Rotavirus vaccine for oral administration |
| 09/25/2013 | CN103316335A Poliovirus vaccine for oral administration |
| 09/25/2013 | CN103316334A Infectious bursal disease live vaccine and production method thereof |
| 09/25/2013 | CN102861333B High-activity composite antibody oral preparation for resisting bursa fabricius viruses and influenza viruses of chicken |
| 09/25/2013 | CN102698260B Preparation method and application of subunit vaccine for preventing Staphylococcus-induced mammitis of goats |
| 09/25/2013 | CN102614506B Recombinant HPV16L2 protein vaccine and preparation method thereof |
| 09/25/2013 | CN102453091B Tetanus toxoid monoclonal antibody and preparation method and application thereof |
| 09/25/2013 | CN102174105B Antibodies directed to HER-3 and uses thereof |
| 09/25/2013 | CN101351225B Tumor-targeted nanodelivery systems to improve early mri detection of cancer |
| 09/24/2013 | US8541649 Brassinosteroid regulated kinases (BRKs) that mediate brassinosteroid signal transduction and uses thereof |
| 09/24/2013 | US8541553 Antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoprotein |
| 09/24/2013 | US8541377 Optimized dengue virus entry inhibitory peptide (DN81) |
| 09/24/2013 | US8541376 Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 09/24/2013 | US8541230 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 09/24/2013 | US8541179 Immunodetection assay for Mycobacterium tuberculosis complex |
| 09/24/2013 | US8541178 Analysis of antibody drug conjugates by bead-based affinity capture and mass spectrometry |
| 09/24/2013 | US8541167 Methods and compositions for vaccination |
| 09/24/2013 | US8541033 Production of human antibodies using NOD/SCID/γcnull mice |
| 09/24/2013 | US8541029 Article and method for focused delivery of therapeutic and/or diagnostic materials |
| 09/24/2013 | US8541023 Immunogenic compositions containing phospholipid |